Published in Cancer Weekly, September 23rd, 2003
"p16(INK4A) is translated from alpha transcript and p14(ARF) is from beta transcript. These two proteins, which are inactivated in some human malignancies, are possible tumor suppressor candidates," wrote Y.K. Lee and colleagues, Hallym University, College of Medicine.
"In this study, we investigated the expression of p16(INK4A) and p14(ARF) mRNAs in hematological...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.